Risk Factors for Endometrial Cancer in Black Women

N/AActive Not RecruitingNCT00514254

Memorial Sloan Kettering Cancer Center59 enrolled

Overview

RATIONALE: Learning about the risk factors for endometrial cancer in black women may help the study of endometrial cancer in the future. PURPOSE: This clinical trial is studying risk factors for endometrial cancer in black women.

OBJECTIVES: * Establish and evaluate procedures for conducting a hospital-based case-control study of risk factors for endometrial cancer in black women. OUTLINE: This is a multicenter study. Participants complete questionnaires about lifestyle factors and their usual diet and measure their waist and hips. Saliva or buccal specimens are collected for future research. PROJECTED ACCRUAL: * A total of 30 cases and 30 controls will be accrued for this study.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Endometrial Cancer

Interventions

questionnaire administrationOTHER

study of socioeconomic and demographic variablesOTHER

evaluation of cancer risk factorsPROCEDURE

Eligibility

Sex: FEMALEMin age: 21 YearsHealthy volunteers:

Medical Language ↔ Plain English

DISEASE CHARACTERISTICS: * Cases * Diagnosed with endometrial cancer within the past year * Self-identified as being black, African-American, black Hispanic, African, or Afro-Caribbean * Healthy controls * Self-identified as being black, African-American, black Hispanic, African, or Afro-Caribbean * No history of endometrial or other cancer (except non-melanoma skin cancer) * No prior hysterectomy PATIENT CHARACTERISTICS: * Speak English * No medical condition that would make it difficult to complete the interview PRIOR CONCURRENT THERAPY: * See Disease Characteristics

Locations (4)

SUNY Downstate Medical Center

Brooklyn, New York, United States

City College of New York

New York, New York, United States

Memorial Sloan Kettering Cancer Center

New York, New York, United States

Montefiore Medical Center

The Bronx, New York, United States

Outcomes

Primary Outcomes

Number and percentage of potential cases and controls approached who are found to be eligible for the study and reasons for being ineligible (including language)

Time frame: 2 years

Number and percentage of cases and controls approached who sign informed consent

Time frame: 2 years

Number and percentage of cases and controls who complete each part of the study (main questionnaire, diet questionnaire, saliva/buccal specimen)

Time frame: 2 years

Proportion of questions with missing data

Time frame: 2 years

Interviewer's evaluation of interview quality and respondent cooperation

Time frame: 2 years

Number and percentage of cases who are willing to have tumor specimens used for future research

Time frame: 2 years

Characteristics of cases and controls (demographics, main risk factors, and use of health care and screening)

Time frame: 2 years

Proportion of participants who rate the study positively on each measure in the post-interview assessment and respondents' suggested changes to the study

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.